Soleno Therapeutics (SLNO) Prepaid Assets (2013 - 2026)
Soleno Therapeutics (SLNO) reported Prepaid Assets of $6.3 million for Q1 2026, down 66.62% year-over-year from $19.0 million in Q1 2025, and down 10.97% quarter-over-quarter from $7.1 million in Q4 2025.
Soleno Therapeutics (SLNO) Prepaid Assets (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 14 years of Prepaid Assets data on file, last reported at $6.3 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $6.3 million, down 66.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (down 66.62% YoY), and the FY2025 annual result was $7.1 million, up 189.97% from the prior year.
- Prepaid Assets slipped to $6.3 million in Q1 2026 per SLNO's latest filing, from $7.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $19.0 million in Q1 2025 and troughed at $821000.0 in Q3 2022.
- A 5-year average of $3.2 million and a median of $1.4 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets surged 1088.28% in 2025, then sank 66.62% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $1.0 million in 2022, then jumped by 60.48% to $1.7 million in 2023, then soared by 46.21% to $2.5 million in 2024, then soared by 189.97% to $7.1 million in 2025, then dropped by 10.97% to $6.3 million in 2026.
- Business Quant data shows SLNO's Prepaid Assets at $6.3 million in Q1 2026, $7.1 million in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.33 Mn |
| Dec 31, 2025 | 7.11 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 2.97 Mn |
| Mar 31, 2025 | 18.97 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 821,000.00 |
| Jun 30, 2022 | 824,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 702,000.00 |
| Jun 30, 2021 | 948,000.00 |